Carbon-based Glyconanoparticle Production Service
Overview of Carbon-based Glyconanoparticle
In the realm of elemental abundance, carbon stands unparalleled, manifesting in its pristine state through an array of allotropic forms. Carbon nanodots, meticulously crafted from this pure essence, epitomize stability, prowess in electrical and thermal conduction, and a mechanical fortitude that defies conventional boundaries—exhibiting extraordinary rigidity, tenacity, and resilience. Their biocompatibility is matched by a negligible toxicity, while their inherent hydrophobicity, rooted in sp2 hybridization, underscores a surface chemistry distinctly averse to aqueous interaction. Based on our GlycoNano™ Platform, CD BioGlyco focuses on developing carbon-based glyconanoparticles, including graphene and its derivatives, carbon nanotubes, carbon dots, and fullerenes.
Glyconanotech: Innovating with Carbon-based Glyconanoparticles
Carbon Fullerene-based Glyconanoparticle Production

Fullerenes are highly regarded for their biocompatibility and effectiveness as platforms for multivalent carbohydrate presentation. The octahedral symmetry and globular architecture of the C60 fullerene core facilitate a uniform 3D distribution of carbohydrates, enhancing their bioactivity and presentation. Therefore, we provide the production of carbon fullerene-based glyconanoparticles. Our glycofullerenes, are particularly promising for pancreatic cancer research due to their localization within the nuclear envelope and ability to generate reactive oxygen species under blue LED illumination.
Carbon Nanotube-based Glyconanoparticle Production Service

We use different approaches to obtain carbon nanotube-based glyconanoparticles, encompassing single-walled and multi-walled, are synthesized by attaching glycans to the nanotube surfaces to create biocompatible, multivalent platforms. These glycoconjugates leverage the unique physicochemical, mechanical, and electrical properties of CNTs, making them attractive for various biological applications. Different synthesis techniques, such as covalent functionalization and non-covalent wrapping, are employed to attach glycans, enabling targeted delivery and enhanced bioactivity in medical applications.
Carbon Dot-based Glyconanoparticle Production Service

Carbon nanodots epitomize a cutting-edge class of carbon-based fluorescing nanomaterials, celebrated as a revolutionary substitute to traditional metallic fluorescent nanoparticles. Their allure stems from the straightforward and cost-effective synthesis process, coupled with minimal toxicity and unparalleled photoelectric and physico-chemical attributes. We also provide carbon dot-based glyconanoparticle production that has gained significant traction as a transformative nanotechnological advancement. Leveraging the exceptional properties of carbon dots, which are low-toxic, stable, and tunable in fluorescence, we integrate glycosides through post-synthetic functionalization. This method ensures that the original structure of the carbohydrate precursors remains intact, enhancing the biocompatibility and bioavailability of the resulting glyconanoparticles.
Graphene-based Glyconanoparticle Production Service

Graphene materials are celebrated for their extensive surface area, chemical stability, electrical conductivity, and photoelectric properties. Furthermore, their high biological tolerance renders them optimal for deployment as functional nanomaterials in nanomedicine, microelectronics, and wearable devices. Therefore, we employ both non-covalent π–π stacking interactions and covalent binding methodologies to achieve glycoconjugation. Our glycan decoration markedly augments the water solubility, colloidal stability, and biocompatibility of these carbon-based nanomaterials, diminishing their propensity to aggregate in aqueous solutions. Additionally, the incorporation of carbohydrates endows the final compounds with biological targeting capabilities, enabling them to engage with biological receptors effectively.
Workflow of Magnetic Glyconanoparticle Manufacture
Carbon Nanoparticle Modification
In the initial stage of the synthesis protocol, we perform the chemical alteration of carbon-based nanoparticle. This transformation is pivotal as it furnishes the requisite reactive positions for the subsequent bonding of numerous sugar units. The modification generally entails the derivatization of the carbon-based nanoparticle with suitable chemical entities that are later employed for the tethering of carbohydrate constituents.
Attachment of Sugar Molecules
Once the carbon-based nanoparticle is modified, we conduct the attachment of multiple sugar molecules. The modified carbon nanoparticle has multiple active sites that can be used to graft carbohydrate groups simultaneously. This multivalent approach allows for the rapid construction of glyconanoparticles with well-defined glycan presentations. The attachment process often involves the use of linkers or spacers to ensure the proper spacing and orientation of the sugar molecules around the carbon nanoparticle core.
Purification and Characterization
After the attachment of sugar molecules, we purify the glyconanoparticles to remove any unreacted starting materials or by-products. This is typically achieved through precipitation, dialysis, or column chromatography. Following purification, the glyconanoparticles are characterized to confirm their structure and functionality. Common characterization techniques include Nuclear Magnetic Resonance (NMR), mass spectrometry (MS), and transmission electron microscopy (TEM).

Publication Data
DOI: 10.3390/nano12152547
Journal: Nanomaterials
Published: 2022
IF: 4.4
Result: In this review, the authors systematically summarize the latest research on the various types of fullerenes studied for antiviral applications. They discuss the structural advantages of fullerenes, present different modification strategies involving the addition of functional groups, evaluate how structural variations affect antiviral activity, and describe the possible antiviral mechanisms. The authors discuss the development of a novel class of hexakis-adduct glycofullerene derivatives as potent multivalent spherical ligands for inhibiting cell infection by pseudotyped Ebola virus particles. They highlight the advantages of using fullerenes as scaffolds due to their three-dimensional structure and controlled functionalization capabilities, which enable the creation of multivalent systems that mimic the surface of pathogens like HIV. The study demonstrates that the hexakis-adduct glycofullerene derivative containing 36 mannoses has significant antiviral activity with an IC50 of 0.3 μM in a pseudotyped Ebola infection model. The authors also explore how the spatial arrangement and valence of the glycofullerene sugars affect antiviral efficacy, suggesting that efficient interaction with receptors is crucial for enhancing antiviral activity.
Applications
- Carbon-based glyconanoparticle can serve as nanocarriers for delivering therapeutic drugs and genes specifically to cancer cells, enhancing the efficacy of treatment while minimizing side effects.
- Carbon-based glyconanoparticle can be used as fluorescent labels for tracking the movement and behavior of cells and biomolecules in vitro and in vivo.
- Carbon-based glyconanoparticle can be used to detect specific glycan-binding receptors on the surface of live cells and pathogens.
Advantages
- We possess in-depth knowledge and extensive experience in the synthesis and application of various carbon-based glyconanoparticles, including fullerenes, graphene, carbon nanotubes, and carbon dots.
- We utilize advanced synthesis techniques, such as covalent functionalization, non-covalent wrapping, and π–π stacking interactions, to achieve precise glycoconjugation.
- Our glyconanoparticles are designed to enhance biocompatibility and bioactivity through the incorporation of carbohydrates.
Frequently Asked Questions
- What glycans can we conjugate with carbon nanoparticles?
We can provide glycans such as maltose, galactose, and mannose, glucose, cyclodextrin, chitosan, and dextran, or hyaluronic acid for conjugation with carbon nanoparticles. -
What parameters need to be considered when designing carbon-based glyconanoparticles?
Key considerations when designing carbon-based glyconanoparticles include multivalency, the nature and spatial arrangement of carbohydrates (taking into account the flexibility and chemical properties of linkers), their distribution around the carbon nanoscale scaffold, as well as the size and shape of the carbon nanoplatform.
At CD BioGlyco, we offer development of glycan-functionalized nanomaterials, that has been harnessed to present glycans in a multivalent manner, each with distinct architectural nuances. This array of configurations serves as a crucible for the study of multivalent carbohydrate-mediated mechanisms and their symbiotic interactions with biological receptors. If you want to know more about our Glyconanoparticle Develpoment Service, contact us!
References
- DiLillo, A.M.; et al. Glycopolymer-wrapped carbon nanotubes show distinct interaction of carbohydrates with lectins. Frontiers in Chemistry. 2022, 10: 852988.
- Xu, P.Y.; et al. Progress in antiviral fullerene research. Nanomaterials. 2022, 12(15): 2547.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





